Latest News and Press Releases

– Clearance opens up the potential breakthrough opportunity in the Upper GI market, an area of high unmet clinical need – – Technological advancements featured in new generation of the Pure-Vu...

– A special 510(k), according to FDA guidance, is usually reviewed within 30 days of receipt – – Pure-Vu Gen 4 platform opens up the Upper GI market, reduces the cost-of-goods by approximately 50%...

– Amended agreement eliminates approximately $1.0M in contingent royalty obligations from balance sheet –  – Canceled royalty rights in exchange for common stock expected to improve Company’s...

FORT LAUDERDALE, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes...

FORT LAUDERDALE, Fla., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes...

On track to submit planned special 510(k) for Pure-Vu Gen 4 Gastro and Colon to the FDA in Q4 2023;Received system wide approval in the Banner Medical Hospital Network and installed the first system...

FORT LAUDERDALE, Fla., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes...

Implementation of the Pure-Vu system designed to improve efficiencies and outcomes of GI endoscopy proceduresInitial agreement expected to provide an easier sales process to the other more than 30...

Pure-Vu system featured in live case during an underwater large polyp resection in the colonOver 1,000 physicians registered for IECED Live Endoscopy Course from across Latin AmericaPure-Vu Gen 4...

Company completes corporate reorganization focused on reducing operating costs while supporting key value creation drivers, including seeking key FDA approvals and pursuit of strategic partnerships to...